Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage

Hwa Jung Sung, Se Ryeon Lee, In Keun Choi, Yong Park, Chul Won Choi, Hyeoung Joon Kim, Ho Young Yhim, Byung Soo Kim

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint Dive into the research topics of 'Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage'. Together they form a unique fingerprint.

Medicine & Life Sciences